CollPlant Biotechnologies (CollPlant Biotechnologies) FCF Margin % : -860.87% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CollPlant Biotechnologies's Free Cash Flow for the three months ended in Dec. 2023 was $-2.57 Mil. CollPlant Biotechnologies's Revenue for the three months ended in Dec. 2023 was $0.30 Mil. Therefore, CollPlant Biotechnologies's FCF Margin % for the quarter that ended in Dec. 2023 was -860.87%.

As of today, CollPlant Biotechnologies's current FCF Yield % is -5.07%.

The historical rank and industry rank for CollPlant Biotechnologies's FCF Margin % or its related term are showing as below:

CLGN' s FCF Margin % Range Over the Past 10 Years
Min: -6789.47 Med: -195.67 Max: 5.83
Current: -33.92

During the past 12 years, the highest FCF Margin % of CollPlant Biotechnologies was 5.83%. The lowest was -6789.47%. And the median was -195.67%.

CLGN's FCF Margin % is ranked better than
65.2% of 1046 companies
in the Biotechnology industry
Industry Median: -145.305 vs CLGN: -33.92

CollPlant Biotechnologies FCF Margin % Historical Data

The historical data trend for CollPlant Biotechnologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies FCF Margin % Chart

CollPlant Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-310.35

-80.98

5.83

-5,021.40

-33.92

CollPlant Biotechnologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-6,293.10	-830.25	-40.07	15,193.02	-860.87

Competitive Comparison of CollPlant Biotechnologies's FCF Margin %

For the Biotechnology subindustry, CollPlant Biotechnologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CollPlant Biotechnologies's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's FCF Margin % falls into.

CollPlant Biotechnologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CollPlant Biotechnologies's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-3.717	/	10.959
	=	-33.92 %

CollPlant Biotechnologies's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-2.574	/	0.299
	=	-860.87 %

CollPlant Biotechnologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

CPT:Germany

Address

4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104

Website

https://www.collplant.com

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.